145 related articles for article (PubMed ID: 32470482)
1. Cell-penetrating peptide enhanced insulin buccal absorption.
Xu Y; Zhang X; Wang N; Pei X; Guo Y; Wang J; Barth S; Yu F; Lee SJ; He H; Yang VC
Int J Pharm; 2020 Jun; 584():119469. PubMed ID: 32470482
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of deformable nanovesicles based on insulin-phospholipid complex for enhancing buccal delivery of insulin.
Xu Y; Zhang X; Zhang Y; Ye J; Wang HL; Xia X; Liu Y
Int J Nanomedicine; 2018; 13():7319-7331. PubMed ID: 30519017
[TBL] [Abstract][Full Text] [Related]
3. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
[TBL] [Abstract][Full Text] [Related]
4. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
5. Noncovalent Strategy with Cell-Penetrating Peptides to Facilitate the Brain Delivery of Insulin through the Blood-Brain Barrier.
Kamei N; Yamaoka A; Fukuyama Y; Itokazu R; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(4):546-554. PubMed ID: 29607927
[TBL] [Abstract][Full Text] [Related]
6. The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption.
He H; Sheng J; David AE; Kwon YM; Zhang J; Huang Y; Wang J; Yang VC
Biomaterials; 2013 Oct; 34(31):7733-43. PubMed ID: 23863452
[TBL] [Abstract][Full Text] [Related]
7. Development of a hydroxypropyl methyl cellulose/polyacrylic acid interpolymer complex formulated buccal mucosa adhesive film to facilitate the delivery of insulin for diabetes treatment.
Chen Y; Zhang L; Xu J; Xu S; Li Y; Sun R; Huang J; Peng J; Gong Z; Wang J; Tang L
Int J Biol Macromol; 2024 Jun; 269(Pt 2):131876. PubMed ID: 38685543
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycaemic effect of a novel insulin buccal formulation on rabbits.
Xu HB; Huang KX; Zhu YS; Gao QH; Wu QZ; Tian WQ; Sheng XQ; Chen ZX; Gao ZH
Pharmacol Res; 2002 Nov; 46(5):459-67. PubMed ID: 12419651
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
Kamei N; Nielsen EJ; Khafagy el-S; Takeda-Morishita M
Ther Deliv; 2013 Mar; 4(3):315-26. PubMed ID: 23442079
[TBL] [Abstract][Full Text] [Related]
10. Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.
Fukuoka Y; Khafagy ES; Goto T; Kamei N; Takayama K; Peppas NA; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(5):811-814. PubMed ID: 29709919
[TBL] [Abstract][Full Text] [Related]
11. Semi-interpenetrating network (sIPN) co-electrospun gelatin/insulin fiber formulation for transbuccal insulin delivery.
Xu L; Sheybani N; Ren S; Bowlin GL; Yeudall WA; Yang H
Pharm Res; 2015 Jan; 32(1):275-85. PubMed ID: 25030186
[TBL] [Abstract][Full Text] [Related]
12. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD
Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
[TBL] [Abstract][Full Text] [Related]
14. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
[TBL] [Abstract][Full Text] [Related]
15. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.
Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M
J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720
[TBL] [Abstract][Full Text] [Related]
16. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.
Niu Z; Samaridou E; Jaumain E; Coëne J; Ullio G; Shrestha N; Garcia J; Durán-Lobato M; Tovar S; Santander-Ortega MJ; Lozano MV; Arroyo-Jimenez MM; Ramos-Membrive R; Peñuelas I; Mabondzo A; Préat V; Teixidó M; Giralt E; Alonso MJ
J Control Release; 2018 Apr; 276():125-139. PubMed ID: 29518466
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the buccal delivery of deformable nanovesicles based on insulin-phospholipid complex: an
Yang Y; Guo Y; Xu Y; Meng Y; Zhang X; Xia X; Liu Y
Drug Deliv; 2020 Dec; 27(1):900-908. PubMed ID: 32597266
[TBL] [Abstract][Full Text] [Related]
18. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
[TBL] [Abstract][Full Text] [Related]
19. Facilitated Buccal Insulin Delivery via Hydrophobic Ion-Pairing Approach: In vitro and ex vivo Evaluation.
Bashyal S; Seo JE; Keum T; Noh G; Lamichhane S; Kim JH; Kim CH; Choi YW; Lee S
Int J Nanomedicine; 2021; 16():4677-4691. PubMed ID: 34262275
[TBL] [Abstract][Full Text] [Related]
20. [Lysalbinic acid--a new absorption enhancer for the buccal delivery of peptide drugs].
Starokadomskiĭ PL; Dubeĭ IIa
Ukr Biokhim Zh (1999); 2005; 77(6):79-85. PubMed ID: 19618746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
